Assistant Professor, Pennsylvania State University
With increasing numbers of real-time PCR users purchasing digital PCR due to its reduction in cost, absolute quantification, improved sensitivity, precision and greater robustness; and with the gene amplification market predicted to grow to $4.94 billion by 2021, this conference provides a timely opportunity to learn first-hand about dPCR whilst also keeping up to date with latest developments and strategies in qPCR.
The congress will examine the latest developments, opportunities and applications of both dPCR and qPCR through case studies across diverse areas such as oncology, infectious diseases, vaccines, prenatal diagnostics, clinical applications, microbiology, point-of-care diagnostics and other novel applications.
Some of the topics to be covered:
Day One, Stream One – Digital PCR: Possibilities & Opportunities
Day One, Stream Two – qPCR: Strategies & Developments
Day Two, Stream One – Healthcare Case Studies
The 2017 Advisory Panel includes:
Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School
Head of Genetic Engineering and Model Validation Department, Mouse Clinical Institute, France
Professor of Microbiology and Molecular Genetics, Rutgers and Director, Office of Technology Transfer, Public Health Research Institute